Skip to main content

McGlynn Margaret G's Form 4 filing

Amicus Therapeutics, Inc. (FOLD) · filed Mar 6, 2024

Accession no.
0000950170-24-027334
Filed
Mar 6, 2024
Trade date
Mar 4-5, 2024
Filing delay
2 days
Rule 10b5-1 plan
Checked

This filing lists 4 non-derivative transactions and 2 derivative transactions. Open-market sales total $200.2K. It was filed 2 days after the trade.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
McGlynn Margaret GCIK 0001215126Director

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Mar 4, 2024Common StockMOption exerciseAcquired+7,500$2.80+$21,00066,789Direct
Mar 4, 2024Common StockSSaleDisposed−7,500$13.29−$99,67559,289Direct
Mar 5, 2024Common StockMOption exerciseAcquired+7,500$2.80+$21,00066,789Direct
Mar 5, 2024Common StockSSaleDisposed−7,500$13.40−$100,50059,289Direct

Derivative securities (Table II)

Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.

Derivative transactions
Trade dateSecurityTransactionUnderlying sharesUnit priceValueHeld afterOwnershipFlags
Mar 4, 2024Common StockMOption exerciseDisposed−7,500$0.00$07,500Direct
Mar 5, 2024Common StockMOption exerciseDisposed−7,500$0.00$00Direct

Footnotes

Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.

Read the original on SEC EDGAR (opens in a new tab)